2025 National Medical Insurance Drug List Released with 114 New Additions, Including 50 Class 1 Innovative Drugs

Deep News
Dec 07, 2025

The 2025 High-Quality Development Conference for Innovative Drugs was held this morning (December 7) in Guangzhou, where the 2025 National Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance Drug List and the first edition of the Commercial Health Insurance Innovative Drug List were announced.

This marks the eighth adjustment to the National Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance Drug List since the establishment of the National Healthcare Security Administration. The updated list includes 114 newly added drugs, 50 of which are Class 1 innovative drugs. The inaugural Commercial Health Insurance Innovative Drug List features 19 drugs, covering treatments ranging from CAR-T therapies for cancer to Alzheimer's disease medications that have garnered significant public attention.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10